Damora Therapeutics (DMRA) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO, with board members and external auditor present for questions.

• Voting procedures and access to agenda and rules of conduct explained to shareholders.

• Record date, notice of meeting, and availability of proxy materials and annual reports confirmed.

Board and executive committee updates

• Two director nominees, Michael Landsittel and Dr. Cameron Turtle, presented for election to serve until the 2029 annual meeting.

• Details on nominees' backgrounds provided in the proxy statement.

Shareholder proposals

• Four proposals presented: election of directors, advisory vote on executive compensation, advisory vote on frequency of future compensation votes, and ratification of auditor.

• Board recommends voting in favor of all proposals, with a one-year frequency for future compensation votes.